Branko Cuglievan

Clinical trials

• A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients

  Principal investigator · Withdrawn · Phase 1

  M.D. Anderson Cancer Center

  2026
• A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias

  Principal investigator · Withdrawn · Phase 1

  M.D. Anderson Cancer Center

  2025
• A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

  Principal investigator · Recruiting · Phase 1

  M.D. Anderson Cancer Center

  2025–2030
• Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population

  Principal investigator · Completed

  Leuko Labs, Inc.

  2021–2023